2017
DOI: 10.1186/s13256-017-1205-7
|View full text |Cite
|
Sign up to set email alerts
|

Subepithelial rectal gastrointestinal stromal tumor – the use of endoscopic ultrasound-guided fine needle aspiration to establish a definitive cytological diagnosis: a case report

Abstract: BackgroundGastrointestinal stromal tumors are the most common mesenchymal neoplasms affecting the gastrointestinal tract. The stomach is the most common location to be affected, and the rectum one of the rarest, but the whole gastrointestinal tract remains susceptible. Gastrointestinal stromal tumors account for only 0.1% of rectal tumors. Currently, endoscopic ultrasound plays an essential role in the diagnostic process of gastrointestinal stromal tumors, especially when the affected sites have a worse outcom… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
8
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 37 publications
0
8
0
Order By: Relevance
“…However, the diagnostic accuracy of EUS-FNA with cytology is insufficient to verify cellular arrangement and tissue architecture. Procurement of histological samples that yield an adequate amount of tissue suitable for IHC staining is pivotal for personalized management of some lesions, such as metastatic lesions, gastrointestinal stromal tumors, lymphomas, and other uncommon lesions[ 7 , 9 ]. The limitation in achieving diagnosis using EUS-FNA is the pauci-cellular nature of the aspirate with a significant proportion of the collected tissue being distorted or consumed during automated processing and sectioning[ 7 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, the diagnostic accuracy of EUS-FNA with cytology is insufficient to verify cellular arrangement and tissue architecture. Procurement of histological samples that yield an adequate amount of tissue suitable for IHC staining is pivotal for personalized management of some lesions, such as metastatic lesions, gastrointestinal stromal tumors, lymphomas, and other uncommon lesions[ 7 , 9 ]. The limitation in achieving diagnosis using EUS-FNA is the pauci-cellular nature of the aspirate with a significant proportion of the collected tissue being distorted or consumed during automated processing and sectioning[ 7 ].…”
Section: Discussionmentioning
confidence: 99%
“…Tissue architecture and morphology are often difficult to maintain with FNA samples – as a result, typically only providing specimen for cytological analysis. The reduced ability for histologic examination may reduce the diagnostic yield for lesions that require immunohistochemistry, immunophenotyping, or evaluation of histologic architecture such as lymphoma, metastatic lesions, and some subepithelial lesions[ 8 , 9 ]. Inflammatory processes may also adversely affect the diagnostic yield of FNA through associated cellular atypia resulting in false positive cytology[ 1 , 7 , 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…The limitation in achieving diagnosis using EUS-FNA is the pauci-cellular nature of the aspirate with a significant proportion of the collected tissue being distorted or consumed during automated processing and sectioning [17,22]. Procurement of histological samples that yield an adequate amount of tissue suitable for IHC staining is pivotal for personalized management of some lesions, such as metastatic lesions or gastrointestinal stromal tumors (GIST), and other uncommon lesions [12,13,21,22]. In our study, cell-block analysis was possible in 80.41 % of patients after FNA and in 93.42 % after FNB (P < 0.001).…”
Section: Discussionmentioning
confidence: 99%
“…For example, cytological analysis alone may not distinguish inflammation from well-differentiated neoplasia because inflammation results in a reactive and regenerative process leading to cellular changes. In addition, certain conditions, such as lymphoma, neuroendocrine tumors, autoimmune pancreatitis, and stromal tumors, require histological specimens with preserved architecture, necessitating immunohistochemical (IHC) staining and histologic diagnosis [10][11][12][13]. Furthermore, EUS-FNA often requires multiple passes to obtain adequate tissue and rapid on-site evaluation (ROSE) for optimal yield, although it remains unclear to what extent ROSE impacts diagnostic accuracy [7,14,15].…”
Section: Introductionmentioning
confidence: 99%
“…Endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) is central to the accurate diagnosis of subepithelial lesions. Similarly, staging of early neoplastic lesions is also an important step in deciding the best treatment option [1,2]. Unfortunately, the oblique endoscopic view of the linear-array echoendoscope precludes routine cecal intubation.…”
mentioning
confidence: 99%